Novel chiral ionic liquids: physicochemical properties and investigation of the internal rotameric behaviour in the neat system‡

Literature Information

Publication Date 2013-10-28
DOI 10.1039/C3CP53472C
Impact Factor 3.676
Authors

Magdalena B. Foreiter, H. Q. Nimal Gunaratne, Peter Nockemann, Kenneth R. Seddon, Geetha Srinivasan


View Original

Abstract

Optically active S-alkyl-N,N′-bis((S)-1-phenylethyl)thiouronium salts, abbreviated as (S)-[Cnpetu]Y (where Y is an anion; n = 1, 2, 3, 4, 6, 8, 10, 12 or 16), have been prepared and studied by a broad spectrum of analyses. This consists of density, viscosity, and conductivity determination, followed by a discussion of relevant correlations. Unusual trends depending on the S-alkyl chain length were documented for (S)-[Cnpetu][NTf2] series (where [NTf2]− = bis{(trifluoromethyl)sulfonyl}amide), including the viscosity decreasing with increasing chain length, and the conductivity showing a maximum between the S-butyl and the S-hexyl derivative. In addition, a hindered rotamerism of the thiouronium cation in dmso-d6 solution was recognised by 1H and 13C NMR techniques. Thorough analysis of NMR spectra confirmed that the main contribution comes from rotation about the partial double C–S bond. For the first time, a neat thiouronium ionic liquid system has been subjected to quantitative analysis of hindered rotamerism by dynamic NMR coalescence studies, with estimated activation energy for rotation of 63.9 ± 0.4 kJ mol−1. Finally, the application of (S)-[Cnpetu]Y salts as chiral discriminating agents for carboxylates by 1H NMR spectroscopy was further investigated, demonstrating the influence of the S-alkyl chain length on chiral recognition; (S)-[C2petu][NTf2] ionic liquid with the mandelate anion gave the best results.

Related Literature

Probing the effect of substituents and solvent on [Mn(R-sal-N-1,5,8,12)]BPh4: a systematic investigation of SCO properties

Sen-Yu Zhang, Hao-Ze Zhang, Hua-wei Zhou, Sheng-Ze Zhao, Yong-Hua Li, Chao Tang, Shi Wang

2023-12-20 Paper

DOI: 10.1039/D3NJ03277A

Advancements in MXene-based composites for electronic skins

Siavash Iravani

2024-01-02 Review Article

DOI: 10.1039/D3TB02247A

A decellularized matrix enriched collagen microscaffold for a 3D in vitro liver model

Shreemoyee De, Ashwini Vasudevan, Dinesh M. Tripathi, Savneet Kaur

2023-12-04 Paper

DOI: 10.1039/D3TB01652H

153Sm-labeled Fe3O4@lapatinib nanoparticles as a potential therapeutic agent for breast cancer: synthesis, quality control, and in vivo evaluation

Thanh Minh Pham, Dong Vu Cao, Ho Hong Quang Dang, Phuoc Minh Thanh Mai, Thanh Binh Nguyen, Ngoc Bao Nam Dinh, Thi Khanh Giang Nguyen, Thi Mai Huong Le, Van Dat Doan, Duc Thuan Nguyen

2023-12-11 Paper

DOI: 10.1039/D3TB01957H

Portable microfluidic plasmonic chip for fast real-time cardiac troponin I biomarker thermoplasmonic detection

Andreea Campu, Ilinca Muresan, Monica Potara, Florin-Leontin Lazar

2023-11-17 Paper

DOI: 10.1039/D3TB02190D

A sustainable and self-healable silk fibroin nanocomposite with antibacterial and drug eluting properties for 3D printed wound dressings

Sana Sheybanikashani, Nooshin Zandi, Danial Hosseini, Roya Lotfi

2023-12-15 Paper

DOI: 10.1039/D3TB02363J

An NIR-II-photoresponsive CoSnO3 nanozyme for mild photothermally augmented nanocatalytic cancer therapy

Lang Yan, Siyu Shang, Jinyan Hu, Xiaofang Zhang, Jikuai Chen, Bijiang Geng, Yin Zhao, Jiangbo Zhu

2023-12-04 Paper

DOI: 10.1039/D3TB02018E

A ratiometric fluorescent probe for imaging the fluctuation of HOBr during endoplasmic reticulum stress

Bingpeng Guo, Mengyu Li, Guiwen Hao, Liangchen Wei, Honghan Sa, Jianbin Chen, Wei Shu, Changxiang Shao

2023-12-29 Paper

DOI: 10.1039/D3TB02679E

A multimodal therapy for infected diabetic wounds based on glucose-responsive nanocomposite-integrated microneedles

Qixin Zhou, Xiaodan Li, Nan Gao, Guixia Ling, Peng Zhang

2024-01-16 Paper

DOI: 10.1039/D3TB02609D

You might also like

Compound Q&A

How should waste containing (6-Bromo-2-naphthyl)oxy](dimethyl)(2-methyl-2-propanyl)silane be handled?

Waste containing (6-Bromo-2-naphthyl)oxy](dimethyl)(2-methyl-2-propanyl)silane (...

100751-65-3[(6-Bromo-2-naphthyl...
Compound Q&A

How is 7-Fluoro-4-isoquinolinecarboxylic acid (CAS: 1841081-40-0) typically synthesized?

7-Fluoro-4-isoquinolinecarboxylic acid can be synthesized via a multi-step proce...

1841081-40-07-Fluoro-4-isoquinol...
Compound Q&A

What are the physical and chemical properties of 2,3,5,6-Tetrabromothieno[3,2-b]thiophene (CAS: 124638-53-5)?

2,3,5,6-Tetrabromothieno[3,2-b]thiophene is a crystalline compound with a high m...

124638-53-52,3,5,6-Tetrabromoth...
Compound Q&A

Is 1-[4-(Benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methyl-1H-indole-4-carboxamide (CAS: 1542705-92-9) safe?

1-[4-(Benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methyl-1H-indol...

1542705-92-91-[4-(Benzylamino)-7...
Compound Q&A

What is the market or research trend for imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxylic acid, 3,4-dihydro-3-methyl-4-oxo- (CAS: 113942-30-6)?

The market for imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxylic acid, 3,4-dihydro-3...

113942-30-6Imidazo[5,1-d]-1,2,3...
Compound Q&A

What is 3-(Triisopropylsilyl)propiolaldehyde (CAS: 163271-80-5)?

3-(Triisopropylsilyl)propiolaldehyde is a synthetic organic compound with the CA...

163271-80-53-(Triisopropylsilyl...
Compound Q&A

What regulatory guidelines apply to 6-Nitro-2H-1,4-benzoxazin-3(4H)-one (CAS: 81721-87-1)?

6-Nitro-2H-1,4-benzoxazin-3(4H)-one (CAS: 81721-87-1) is subject to various regu...

81721-87-16-Nitro-2H-1,4-benzo...
Compound Q&A

How should waste containing (3-Fluorophenyl)(4-{[(2-methyl-2-propanyl)oxy]carbonyl}-1-piperazinyl)acetic acid (CAS: 885272-91-3) be handled?

Waste containing (3-Fluorophenyl)(4-{[(2-methyl-2-propanyl)oxy]carbonyl}-1-piper...

885272-91-3(3-Fluorophenyl)(4-{...
Compound Q&A

What are the physical and chemical properties of N,N'-4,4'-Biphenyldiyldiisonicotinamide (CAS: 55119-40-9)?

N,N'-4,4'-Biphenyldiyldiisonicotinamide is a white crystalline solid with a mole...

55119-40-9N,N'-4,4'-Biphenyldi...
Compound Q&A

What industries use 6-Bromo-8-fluoro-2-quinazolinol (CAS: 1036756-15-6)?

6-Bromo-8-fluoro-2-quinazolinol is primarily used in the pharmaceutical industry...

1036756-15-66-Bromo-8-fluoro-2-q...

Source Journal

Physical Chemistry Chemical Physics

Physical Chemistry Chemical Physics
CiteScore: 5.5
Self-citation Rate: 10.3%
Articles per Year: 3036

Physical Chemistry Chemical Physics (PCCP) is an international journal co-owned by 19 physical chemistry and physics societies from around the world. This journal publishes original, cutting-edge research in physical chemistry, chemical physics and biophysical chemistry. To be suitable for publication in PCCP, articles must include significant innovation and/or insight into physical chemistry; this is the most important criterion that reviewers and Editors will judge against when evaluating submissions. The journal has a broad scope and welcomes contributions spanning experiment, theory, computation and data science. Topical coverage includes spectroscopy, dynamics, kinetics, statistical mechanics, thermodynamics, electrochemistry, catalysis, surface science, quantum mechanics, quantum computing and machine learning. Interdisciplinary research areas such as polymers and soft matter, materials, nanoscience, energy, surfaces/interfaces, and biophysical chemistry are welcomed if they demonstrate significant innovation and/or insight into physical chemistry. Joined experimental/theoretical studies are particularly appreciated when complementary and based on up-to-date approaches.

Recommended Compounds

Recommended Suppliers

Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.